MUST Beg to Differ

Thomas Albini, Natalia F. Callaway, Glenn J. Jaffe, William Feuer, Janet Davis, Debra Goldstein, Careen Lowder, Phoebe Lin, Quan Nguyen, Sunil Srivastava, David Callanan, Anat Galor, Raquel Goldhardt, Harry Flynn

Research output: Contribution to journalEditorial

Abstract

The authors provide a significant interpretation of the National Eye Institute-sponsored Multicenter Uveitis Steroid Treatment study, in which patients with severe, non-infectious intermediate, posterior, or panuveitis were randomly assigned to receive local treatment using the sutured intravitreal fluocinolone acetonide implant or systemic treatment consisting of oral steroids and conventional steroid-sparing immunosuppression, with a primary outcome of visual acuity at 2 years of follow-up. The authors also present evidence-based guidance for the treatment of noninfectious posterior segment involving uveitis. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:266-268.].

Original languageEnglish (US)
Pages (from-to)266-268
Number of pages3
JournalOphthalmic surgery, lasers & imaging retina
Volume50
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Steroids
Uveitis
Fluocinolone Acetonide
National Eye Institute (U.S.)
Panuveitis
Therapeutics
Immunosuppression
Visual Acuity
Retina
Lasers

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Cite this

Albini, T., Callaway, N. F., Jaffe, G. J., Feuer, W., Davis, J., Goldstein, D., ... Flynn, H. (2019). MUST Beg to Differ. Ophthalmic surgery, lasers & imaging retina, 50(5), 266-268. https://doi.org/10.3928/23258160-20190503-01

MUST Beg to Differ. / Albini, Thomas; Callaway, Natalia F.; Jaffe, Glenn J.; Feuer, William; Davis, Janet; Goldstein, Debra; Lowder, Careen; Lin, Phoebe; Nguyen, Quan; Srivastava, Sunil; Callanan, David; Galor, Anat; Goldhardt, Raquel; Flynn, Harry.

In: Ophthalmic surgery, lasers & imaging retina, Vol. 50, No. 5, 01.05.2019, p. 266-268.

Research output: Contribution to journalEditorial

Albini, T, Callaway, NF, Jaffe, GJ, Feuer, W, Davis, J, Goldstein, D, Lowder, C, Lin, P, Nguyen, Q, Srivastava, S, Callanan, D, Galor, A, Goldhardt, R & Flynn, H 2019, 'MUST Beg to Differ', Ophthalmic surgery, lasers & imaging retina, vol. 50, no. 5, pp. 266-268. https://doi.org/10.3928/23258160-20190503-01
Albini T, Callaway NF, Jaffe GJ, Feuer W, Davis J, Goldstein D et al. MUST Beg to Differ. Ophthalmic surgery, lasers & imaging retina. 2019 May 1;50(5):266-268. https://doi.org/10.3928/23258160-20190503-01
Albini, Thomas ; Callaway, Natalia F. ; Jaffe, Glenn J. ; Feuer, William ; Davis, Janet ; Goldstein, Debra ; Lowder, Careen ; Lin, Phoebe ; Nguyen, Quan ; Srivastava, Sunil ; Callanan, David ; Galor, Anat ; Goldhardt, Raquel ; Flynn, Harry. / MUST Beg to Differ. In: Ophthalmic surgery, lasers & imaging retina. 2019 ; Vol. 50, No. 5. pp. 266-268.
@article{b84fc93f00c5476389fffc31b4e73e75,
title = "MUST Beg to Differ",
abstract = "The authors provide a significant interpretation of the National Eye Institute-sponsored Multicenter Uveitis Steroid Treatment study, in which patients with severe, non-infectious intermediate, posterior, or panuveitis were randomly assigned to receive local treatment using the sutured intravitreal fluocinolone acetonide implant or systemic treatment consisting of oral steroids and conventional steroid-sparing immunosuppression, with a primary outcome of visual acuity at 2 years of follow-up. The authors also present evidence-based guidance for the treatment of noninfectious posterior segment involving uveitis. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:266-268.].",
author = "Thomas Albini and Callaway, {Natalia F.} and Jaffe, {Glenn J.} and William Feuer and Janet Davis and Debra Goldstein and Careen Lowder and Phoebe Lin and Quan Nguyen and Sunil Srivastava and David Callanan and Anat Galor and Raquel Goldhardt and Harry Flynn",
year = "2019",
month = "5",
day = "1",
doi = "10.3928/23258160-20190503-01",
language = "English (US)",
volume = "50",
pages = "266--268",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",
number = "5",

}

TY - JOUR

T1 - MUST Beg to Differ

AU - Albini, Thomas

AU - Callaway, Natalia F.

AU - Jaffe, Glenn J.

AU - Feuer, William

AU - Davis, Janet

AU - Goldstein, Debra

AU - Lowder, Careen

AU - Lin, Phoebe

AU - Nguyen, Quan

AU - Srivastava, Sunil

AU - Callanan, David

AU - Galor, Anat

AU - Goldhardt, Raquel

AU - Flynn, Harry

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The authors provide a significant interpretation of the National Eye Institute-sponsored Multicenter Uveitis Steroid Treatment study, in which patients with severe, non-infectious intermediate, posterior, or panuveitis were randomly assigned to receive local treatment using the sutured intravitreal fluocinolone acetonide implant or systemic treatment consisting of oral steroids and conventional steroid-sparing immunosuppression, with a primary outcome of visual acuity at 2 years of follow-up. The authors also present evidence-based guidance for the treatment of noninfectious posterior segment involving uveitis. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:266-268.].

AB - The authors provide a significant interpretation of the National Eye Institute-sponsored Multicenter Uveitis Steroid Treatment study, in which patients with severe, non-infectious intermediate, posterior, or panuveitis were randomly assigned to receive local treatment using the sutured intravitreal fluocinolone acetonide implant or systemic treatment consisting of oral steroids and conventional steroid-sparing immunosuppression, with a primary outcome of visual acuity at 2 years of follow-up. The authors also present evidence-based guidance for the treatment of noninfectious posterior segment involving uveitis. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:266-268.].

UR - http://www.scopus.com/inward/record.url?scp=85066271146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066271146&partnerID=8YFLogxK

U2 - 10.3928/23258160-20190503-01

DO - 10.3928/23258160-20190503-01

M3 - Editorial

VL - 50

SP - 266

EP - 268

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 5

ER -